What is the ESG rating for AMGN?

Amgen Inc. has the following ESG ratings: MSCI ESG Rating: 81, Sustainalytics ESG Risk: 62, ESG Enterprise Score: BBB.

What are the main strengths of investing in AMGN?

The main strengths of investing in Amgen Inc. include: Has a strong product pipeline with potential blockbuster drugs in development, Is a leader in the biotechnology space and has a large market share, Has a good ESG rating.

What are the potential drawbacks of investing in AMGN?

Potential drawbacks of investing in Amgen Inc. include: Its recent performance has been lacklustre, Faces stiff competition from other companies in the space.

What are the key financial metrics for AMGN?

Key financial metrics for Amgen Inc. include: Market Cap: $14787.45 billion, Dividend Yield: 3.46%.

${quote.companyName} (${symbol}) Stock Analysis

Price Chart

Real-time data provided by Alpha Vantage

Financial Metrics

Market Cap

$269.9B

P/E Ratio

N/A

52-Week High

$319.89

52-Week Low

$219.89

Volume

7,058,709

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Key Statistics

Market Cap$269.9B

P/E Ratio (TTM)N/A

Volume7,058,709

Avg VolumeN/A

52-Week High$319.89

52-Week Low$219.89

Dividend Yield250.00%

BetaN/A

ESG Ratings

Overall ESG Score57.0/100

Environmental42.0/100

Social50.0/100

Governance58.0/100

Peer GroupBiotechnology

Updated: 6/11/2025

AMGN Inc.

AMGN

$269.89

AMGN Inc. (AMGN)

Price Chart

Financial Metrics

Key Statistics

ESG Ratings